Meadow Creek Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Meadow Creek Investment Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$259K	Hold	5,338	–	–	0.01%	949
2019 Q2	$281K	Sell	5,338 -782	-13%	-$44.9K	0.01%	930
2019 Q1	$324K	Sell	6,120 -4,420	-42%	-$217K	0.01%	850
2018 Q4	$433K	Buy	+10,540	New	+$395K	0.01%	689
2018 Q3	–	Sell	-1,496	Closed	-$68K	–	1341
2018 Q2	$68K	Buy	+1,496	New	+$68.1K	﹤0.01%	1237

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Meadow Creek Investment Management's GBT Position: Q3 2019 in Review

Meadow Creek Investment Management held its Global Blood Therapeutics, Inc. (GBT) position steady in Q3 2019 at 5,338 shares worth $259K. The position accounts for 0.01% of the portfolio, ranked #949.

Meadow Creek Investment Management first reported a position in GBT in Q2 2018 and has held it in 5 quarters since. The position peaked at $433K in Q4 2018. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

Meadow Creek Investment Management held 5,338 shares of Global Blood Therapeutics, Inc. worth $259K as of Q3 2019.
Meadow Creek Investment Management left its Global Blood Therapeutics, Inc. share count unchanged in Q3 2019.
Global Blood Therapeutics, Inc. made up 0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #949 holding.
Meadow Creek Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and has held it in 5 quarters since.
Meadow Creek Investment Management's Global Blood Therapeutics, Inc. position peaked at $433K in Q4 2018.
208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.